Article info
PDFExtended report
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
- Correspondence to:
Professor J-Y Reginster
Unité d’Exploration du Metabolisme de l’Os et du Cartilage, CHU Centre Ville, Liège, Belgium; jyreginster{at}ulg.ac.be
Citation
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
Publication history
- Accepted November 27, 2005
- First published December 8, 2005.
Online issue publication
April 12, 2006
Article Versions
- Previous version (8 December 2005).
- Previous version (5 January 2006).
- Previous version (26 January 2006).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases